Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121773774 | 12177377 | 4 | F | 20160116 | 20160707 | 20160315 | 20160711 | EXP | GB-AMGEN-GBRSP2016031057 | AMGEN | 41.00 | YR | A | F | Y | 0.00000 | 20160711 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121773774 | 12177377 | 1 | PS | filgrastim | FILGRASTIM | 1 | Unknown | UNK | U | 103353 | UNKNOWN FORMULATION | ||||||||
| 121773774 | 12177377 | 2 | SS | CLOZARIL | CLOZAPINE | 1 | Oral | UNK | 0 | ||||||||||
| 121773774 | 12177377 | 3 | SS | CLOZARIL | CLOZAPINE | 1 | Oral | UNK | 0 | ||||||||||
| 121773774 | 12177377 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 20 MG, 1/ 1DAYS | 0 | 20 | MG | QD | |||||||
| 121773774 | 12177377 | 5 | C | BISACODYL. | BISACODYL | 1 | Unknown | 5 MG, 1/ 1 DAYS | 0 | 5 | MG | QD | |||||||
| 121773774 | 12177377 | 6 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, 1/ 1DAYS | 0 | 20 | MG | QD | |||||||
| 121773774 | 12177377 | 7 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 121773774 | 12177377 | 8 | C | DOCETAXEL. | DOCETAXEL | 1 | Unknown | UNK | 0 | ||||||||||
| 121773774 | 12177377 | 9 | C | EPIRUBICIN | EPIRUBICIN | 1 | Unknown | UNK | 0 | ||||||||||
| 121773774 | 12177377 | 10 | C | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | UNK | 0 | ||||||||||
| 121773774 | 12177377 | 11 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 1 G, 2 /1DAYS | 0 | 1 | G | BID | |||||||
| 121773774 | 12177377 | 12 | C | PREGABALIN. | PREGABALIN | 1 | Unknown | 150 MG, 2 /1DAYS | 0 | 150 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121773774 | 12177377 | 1 | Invasive ductal breast carcinoma |
| 121773774 | 12177377 | 2 | Product used for unknown indication |
| 121773774 | 12177377 | 4 | Product used for unknown indication |
| 121773774 | 12177377 | 5 | Product used for unknown indication |
| 121773774 | 12177377 | 6 | Product used for unknown indication |
| 121773774 | 12177377 | 7 | Invasive ductal breast carcinoma |
| 121773774 | 12177377 | 8 | Invasive ductal breast carcinoma |
| 121773774 | 12177377 | 9 | Invasive ductal breast carcinoma |
| 121773774 | 12177377 | 10 | Invasive ductal breast carcinoma |
| 121773774 | 12177377 | 11 | Product used for unknown indication |
| 121773774 | 12177377 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121773774 | 12177377 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121773774 | 12177377 | Neutrophil count increased | |
| 121773774 | 12177377 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121773774 | 12177377 | 2 | 20020916 | 0 | ||
| 121773774 | 12177377 | 3 | 20160113 | 0 |